Chewy, Inc. CHWY
4 trading plans running, 16 Form 144 notices for $7.1M
10-Q, 10-K and Form 144What CHWY's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Jul 12, 2024 to Jan 29, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| William Billings Chief Accounting Officer and Treasurer |
Adopted 10b5-1 plan | Jun 30, 2026 | 10-Q Sep 9, 2026 | ||
What the company wroteOn June 30, 2026, William Billings, the Company’s Chief Accounting Officer and Treasurer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2026, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 22,888 shares. | |||||
| Aseemita Malhotra President |
Adopted 10b5-1 plan | Jan 16, 2026 | 10-K Mar 25, 2026 | ||
What the company wroteOn January 16, 2026, Aseemita Malhotra, the Company’s President of Healthcare, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on January 29, 2027, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 76,710 shares. | |||||
| Sumit Singh Chief Executive Officer |
Adopted 10b5-1 plan | Jan 16, 2026 | 10-K Mar 25, 2026 | ||
What the company wroteOn January 16, 2026, Sumit Singh, the Company’s Chief Executive Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on January 29, 2027, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 612,185 shares. | |||||
| Satish Mehta Chief Technology Officer |
Adopted 10b5-1 plan | Sep 23, 2025 | 10-Q Dec 10, 2025 | ||
What the company wroteOn September 23, 2025, Satish Mehta, the Company’s Chief Technology Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2026, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 139,333 shares. | |||||
| William Billings Chief Accounting Officer, Interim Principal Financial Officer, and Principal Accounting Officer |
Ended 10b5-1 plan | Jul 18, 2025 | 10-Q Sep 10, 2025 | ||
What the company wroteOn July 17, 2025, William Billings, the Company’s Chief Accounting Officer, Interim Principal Financial Officer, and Principal Accounting Officer adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on July 31, 2026, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 38,797 shares. On July 18, 2025, William Billings terminated the “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K that he had previously adopted on July 17, 2025, and on that same day adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on July 31, 2026, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 38,797 shares. | |||||
| Satish Mehta Chief Technology Officer |
Ended 10b5-1 plan | Apr 9, 2025 | 10-Q Jun 11, 2025 | ||
What the company wroteOn April 9, 2025, Satish Mehta, the Company’s Chief Technology Officer, terminated the “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K that he had previously adopted on October 6, 2024. On April 9, 2025, Satish Mehta adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 144,469 shares. | |||||
| David Reeder Chief Financial Officer |
Adopted 10b5-1 plan | Oct 6, 2024 | 10-Q Dec 4, 2024 | ||
What the company wroteOn September 11, 2024, David Reeder, the Company’s Chief Financial Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K in the form of a “sell-to-cover” instruction of indefinite duration to instruct the Company to sell shares of Class A common stock to satisfy tax withholding obligations arising from the vesting of RSUs. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The number of shares that will be sold under the arrangement is not currently determinable as the number will vary based on the extent to which vesting conditions are satisfied and the market price of our Class A common stock at the time of settlement. On October 6, 2024, David Reeder, the Company’s Chief Financial Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 581,251 shares. | |||||
| Satish Mehta Chief Technology Officer |
Ended 10b5-1 plan | Oct 2, 2024 | 10-Q Dec 4, 2024 | ||
What the company wroteOn October 2, 2024, Satish Mehta, the Company’s Chief Technology Officer, terminated the “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K that he had previously adopted on July 12, 2024. On October 6, 2024, Satish Mehta adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 541,328 shares. | |||||
| Sumit Singh Chief Executive Officer |
Adopted 10b5-1 plan | Sep 25, 2024 | 10-Q Dec 4, 2024 | ||
What the company wroteOn September 25, 2024, Sumit Singh, the Company’s Chief Executive Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 1,387,271 shares. | |||||
| Aseemita Malhotra President of Chewy Health |
Adopted 10b5-1 plan | Sep 19, 2024 | 10-Q Dec 4, 2024 | ||
What the company wroteOn September 19, 2024, Aseemita Malhotra, the Company's President of Chewy Health, and spouse of the Company's Chief Executive Officer, Sumit Singh, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 142,322 shares. | |||||
| William Billings Chief Accounting Officer |
Adopted 10b5-1 plan | Sep 11, 2024 | 10-Q Dec 4, 2024 | ||
What the company wroteOn September 11, 2024, William Billings, the Company’s Chief Accounting Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K in the form of a “sell-to-cover” instruction of indefinite duration to instruct the Company to sell shares of Class A common stock to satisfy tax withholding obligations arising from the vesting of RSUs. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The number of shares that will be sold under the arrangement is not currently determinable as the number will vary based on the extent to which vesting conditions are satisfied and the market price of our Class A common stock at the time of settlement. | |||||
| Satish Mehta Chief Technology Officer |
Adopted 10b5-1 plan | Jul 12, 2024 | 10-Q Aug 28, 2024 | ||
What the company wroteOn July 12, 2024, Satish Mehta, the Company’s Chief Technology Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on July 14, 2025, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 338,130 shares. | |||||
Show the other 4 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 31, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 4, 2026 | Billings William G. Officer |
4,815 | $111K |
| Nov 2, 2026 | Singh Sumit Member of immediate family of any of the foregoing |
3,228 | $69K |
| Nov 2, 2026 | Singh Sumit Officer, Director |
23,002 | $492K |
| Oct 15, 2026 | Billings William G. Officer |
17,283 | $363K |
| Aug 3, 2026 | Singh Sumit Officer, Director |
43,244 | $995K |
| Aug 3, 2026 | Singh Sumit Member of immediate family of any of the foregoing |
6,233 | $143K |
| Jun 29, 2026 | Hu Da-Wai Officer |
4,203 | $82K |
| May 4, 2026 | Singh Sumit Officer, Director |
83,306 | $2.1M |
| May 4, 2026 | Singh Sumit Member of immediate family of any of the foregoing |
4,220 | $108K |
| Apr 1, 2026 | Hu Da-Wai Officer |
8,149 | $219K |
| Mar 2, 2026 | Deppe Christopher S. Officer |
3,043 | $82K |
| Feb 2, 2026 | Mehta Satish Officer |
13,013 | $377K |
| Dec 3, 2025 | Mehta Satish Officer |
8,872 | $297K |
| Dec 2, 2025 | Singh Sumit Officer, Director |
40,789 | $1.4M |
| Dec 2, 2025 | Mehta Satish Officer |
6,056 | $204K |
| Dec 2, 2025 | Singh Sumit Member of immediate family of any of the foregoing |
639 | $22K |
Show the other 8 notices
From the Form 144 XML filed with the SEC, since Dec 2, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CHWY/export.csv") into a cell.